• Are You Looking for a Top Momentum Pick? Why Inhibrx Biosciences, Inc. (INBX) is a Great Choice Yahoo Finance Thu, 09 Jul 2026 16:00:03 GMT
• Inhibrx Inc explores strategic options as investors watch Nasdaq biotech space AD HOC NEWS Wed, 08 Jul 2026 19:31:48 GMT
• Inhibrx Biosciences (INBX) Following Russell Reshuffle With Valuation Still Hard To Pin Down simplywall.st Wed, 08 Jul 2026 08:36:46 GMT
• How Russell Index Reclassification Toward Growth Benchmarks Will Impact Inhibrx Biosciences (INBX) Investors simplywall.st Thu, 02 Jul 2026 23:37:15 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS: INBX) dropped from Russell 2000 Defensive Index marketscreener.com Mon, 29 Jun 2026 21:22:04 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 16:40:37 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS: INBX) added to Russell 2000 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 11:32:47 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from Russell 2000 Value-Defensive Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Inhibrx Biosciences, Inc.(NasdaqGS: INBX) dropped from Russell 3000E Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• inhibrx biosciences, inc.(nasdaqgs: inbx) added to russell 3000 growth benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Enterprise value to revenue forward of Inhibrx Biosciences, Inc. – NASDAQ:INBX TradingView Sat, 27 Jun 2026 18:14:43 GMT
• Inhibrx Biosciences (INBX) Wins FDA Filing Acceptance, Is More Upside Already Priced In? Sahm Sat, 27 Jun 2026 07:00:00 GMT
• price to sales forward of inhibrx biosciences, inc. – nasdaq:inbx TradingView Sat, 27 Jun 2026 06:26:53 GMT
• Inhibrx Inc outlook after merger closing, shares remain a biotech niche story AD HOC NEWS Thu, 25 Jun 2026 20:27:16 GMT
• inhibrx biosciences, inc. actuals & estimates (nasdaq:inbx) TradingView Thu, 25 Jun 2026 20:23:33 GMT
• inhibrx biosciences inc (inbx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• inhibrx biosciences (inbx) short interest & short float | updated jun 2026 MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• the bull case for inhibrx biosciences (inbx) could change following fda bla acceptance for ozekibart Sahm Wed, 24 Jun 2026 07:23:29 GMT
• Inhibrx Biosciences (INBX) Gains 2.44%, Approaches Key Resistance at $99.93 - Order Block dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• the bull case for inhibrx biosciences (inbx) could change following fda bla acceptance for ozekibart simplywall.st Tue, 23 Jun 2026 07:00:00 GMT
• inhibrx biosciences inc (inbx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• inhibrx biosciences (inbx) stock near analyst target after fda filing for ozekibart simplywall.st Sat, 20 Jun 2026 03:44:45 GMT
• inhibrx biosciences (inbx) stock near analyst target after fda filing for ozekibart Sahm Fri, 19 Jun 2026 07:00:00 GMT
• What is Inhibrx Biosciences, Inc. (INBX) stock_business overview_development history Bitget Fri, 19 Jun 2026 01:00:00 GMT
• inhibrx biosciences inc (inbx) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 09:15:11 GMT
• inhibrx biosciences inc (inbx) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 06:05:39 GMT
• inhibrx biosciences inc (inbx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 01:51:18 GMT
• inhibrx biosciences inc (inbx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:37:05 GMT
• inhibrx biosciences inc (inbx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 21:06:50 GMT
• inhibrx biosciences inc (inbx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:06:49 GMT
• inhibrx biosciences inc (inbx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 20:54:54 GMT
• Exclusive BAC Article: Inhibrx; PDUFA April 14th 2027 Ozekibart Chondrosarcoma, PFS Data INBRX-106 HexAgon HNSCC Patients Q4 2026,... Seeking Alpha Tue, 16 Jun 2026 07:00:00 GMT
• Inhibrx Biosciences stock gains after FDA accepts drug filing By Investing.com Investing.com Australia Tue, 16 Jun 2026 07:00:00 GMT
• inhibrx biosciences inc (inbx) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• inhibrx biosciences inc (inbx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• how fda’s ozekibart bla acceptance for chondrosarcoma could shape inhibrx biosciences (inbx) investors simplywall.st Tue, 16 Jun 2026 05:33:47 GMT
• fda review begins for potential first drug for aggressive bone cancer Stock Titan Mon, 15 Jun 2026 13:15:00 GMT
• Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma PR Newswire Mon, 15 Jun 2026 07:00:00 GMT
• FDA accepts Inhibrx (NASDAQ: INBX) BLA for first chondrosarcoma therapy Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Inhibrx Biosciences stock gains after FDA accepts drug filing Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• FDA Accepts BLA for Ozekibart in Conventional Chondrosarcoma OncLive Mon, 15 Jun 2026 07:00:00 GMT
• FDA accepts Inhibrx filing for rare bone cancer treatment By Investing.com Investing.com Canada Mon, 15 Jun 2026 07:00:00 GMT
• number of shareholders of inhibrx biosciences, inc. – nasdaq:inbx TradingView Sun, 14 Jun 2026 20:17:46 GMT
• inhibrx reports second quarter 2023 financial results and recent corporate highlights GuruFocus Mon, 08 Jun 2026 23:01:15 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Fri, 05 Jun 2026 04:51:44 GMT
• Inhibrx Biosciences (INBX) director granted 15,000 stock options at $95.22 Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• Inhibrx Biosciences (INBX) director receives 15,000 stock options at $95.22 strike Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• inhibrx biosciences (inbx) director receives grant of 15,000 stock options Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• inhibrx biosciences (nasdaq: inbx) investors approve directors and bdo Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• stifel maintains inhibrx biosciences(inbx.us) with buy rating, maintains target price $325 Moomoo Tue, 02 Jun 2026 13:31:00 GMT
• stifel reiterates inhibrx biosciences stock rating on durability data Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Inhibrx Biosciences (INBX) Slips 2% as Stock Tests Key Support Amid Biotech Volatility - Technical Analysis dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Thu, 28 May 2026 10:05:20 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Wed, 27 May 2026 15:23:52 GMT
• inbx stock price, quote & chart | inhibrx biosciences inc (nasdaq:inbx) ChartMill Wed, 27 May 2026 07:00:00 GMT
• Inhibrx Biosciences (INBX) Surges Over 5%: Key Levels and What Lies Ahead - Ichimoku TK Cross dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Mon, 25 May 2026 13:07:42 GMT
• how positive inbrx-106 phase 2 data and narrower losses at inhibrx biosciences (inbx) have changed its investment story simplywall.st Mon, 25 May 2026 07:00:00 GMT
• inhibrx biosciences hits day low of $99.70 amid price pressure MarketsMojo Mon, 25 May 2026 07:00:00 GMT
• inhibrx biosciences (inbx) price target increased by 66.67% to 255.00 MSN Sun, 24 May 2026 12:08:32 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Sat, 23 May 2026 08:37:30 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Fri, 22 May 2026 16:04:21 GMT
• inhibrx biosciences (inbx) price target increased by 66.67% to 255.00 MSN Fri, 22 May 2026 02:13:27 GMT
• inhibrx inc stock (us45720l1070): trial update around ozekibart keeps biotech investors watching AD HOC NEWS Thu, 21 May 2026 20:57:08 GMT
• inhibrx cancer drug reportedly drawing interest of merck and rivals MSN Thu, 21 May 2026 18:48:44 GMT
• this biotech stock surges after positive cancer trial results. what to know. MSN Thu, 21 May 2026 14:34:05 GMT
• transcenta-b: positive interim data from ozekibart mid-stage study; greater china plan under evaluation AASTOCKS.com Thu, 21 May 2026 00:50:00 GMT
• transcenta-b (06628.hk): positive interim data from ozekibart mid-stage study; evaluating greater china plan AASTOCKS.com Thu, 21 May 2026 00:50:00 GMT
• transcenta gains boost as inhibrx’s ozekibart data and fda filing strengthen greater china cancer franchise TipRanks Wed, 20 May 2026 23:49:32 GMT
• inhibrx biosciences' inbrx-106 combo tops keytruda alone in phase 2 cancer study MSN Wed, 20 May 2026 19:39:42 GMT
• inhibrx biosciences, inc. - common stock (nq: inbx The Chronicle-Journal Wed, 20 May 2026 16:11:13 GMT
• a look at inhibrx biosciences (inbx) valuation after hexagon phase 2 data and phase 3 plans simplywall.st Wed, 20 May 2026 07:00:00 GMT
• transcenta-b: positive interim data from ozekibart mid-stage study; greater china plan under evaluation AASTOCKS.com Wed, 20 May 2026 07:00:00 GMT
• inhibrx cancer treatment shows high response rates in head and neck cancer study MSN Mon, 18 May 2026 07:54:29 GMT
• inhibrx biosciences' inbrx-106 combo tops keytruda alone in phase 2 cancer study MSN Sun, 17 May 2026 01:44:21 GMT
• inhibrx cancer treatment shows high response rates in head and neck cancer study MSN Sun, 17 May 2026 00:00:58 GMT
• lifesci capital maintains inhibrx biosciences(inbx.us) with buy rating, maintains target price $230 富途牛牛 Sat, 16 May 2026 23:48:16 GMT
• this biotech stock surges after positive cancer trial results. what to know. MSN Sat, 16 May 2026 00:05:42 GMT
• inhibrx biosciences, inc. - common stock (nq: inbx The Chronicle-Journal Fri, 15 May 2026 20:00:00 GMT
• stifel maintains inhibrx biosciences(inbx.us) with buy rating, raises target price to $325 Moomoo Fri, 15 May 2026 14:02:04 GMT
• perceptive (inbx) reports a 9.99% stake in inhibrx via schedule 13g/a Stock Titan Fri, 15 May 2026 07:00:00 GMT
• viking global holds 1.46m shares in inhibrx (inbx); amendment removes one reporter Stock Titan Fri, 15 May 2026 07:00:00 GMT
• inbx stock price, quote & chart | inhibrx biosciences inc (nasdaq:inbx) ChartMill Fri, 15 May 2026 07:00:00 GMT
• inhibrx & invesco mortgage capital q1 2026 results english.punjabkesari.com Fri, 15 May 2026 06:19:28 GMT
• inhibrx biosciences reports strong phase 2 response data for inbrx 106 and pembrolizumab combination in head and neck cancer BioPharma APAC Fri, 15 May 2026 02:44:24 GMT
• inhibrx biosciences reports strong phase 2 response data for inbrx 106 and pembrolizumab combination in head and neck cancer BioPharma APAC Thu, 14 May 2026 10:29:11 GMT
• Inhibrx Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Thu, 14 May 2026 07:00:00 GMT
• inhibrx biosciences (inbx) announces positive interim results from phase 2 portion of hexagon study Insider Monkey Thu, 14 May 2026 07:00:00 GMT
• press release: inhibrx reports first quarter 2026 financial results Moomoo Thu, 14 May 2026 07:00:00 GMT
• inhibrx inc stock (us45720l1070): biotech firm in virtus etf holdings AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• inhibrx seeks fda ok for cancer drug as q1 loss totals $33.4m Stock Titan Thu, 14 May 2026 07:00:00 GMT
• inhibrx biosciences (inbx) advances ozekibart bla and inbrx-106 after strong oncology data Stock Titan Thu, 14 May 2026 07:00:00 GMT
• inhibrx biosciences (inbx) cuts q1 2026 loss, boosts cash but ups debt Stock Titan Thu, 14 May 2026 07:00:00 GMT
• inhibrx cancer treatment shows high response rates in head and neck cancer study MSN Thu, 14 May 2026 02:04:00 GMT
• inhibrx biosciences' inbrx-106 combo tops keytruda alone in phase 2 cancer study MSN Thu, 14 May 2026 02:01:35 GMT
• this biotech stock surges after positive cancer trial results. what to know. MSN Thu, 14 May 2026 01:31:21 GMT
• inhibrx biosciences reports strong phase 2 response data for inbrx 106 and pembrolizumab combination in head and neck cancer BioPharma APAC Wed, 13 May 2026 07:00:00 GMT
• inbx stock price, quote & chart | inhibrx biosciences inc (nasdaq:inbx) ChartMill Wed, 13 May 2026 07:00:00 GMT
• inhibrx cancer treatment shows high response rates in head and neck cancer study MSN Wed, 13 May 2026 02:55:58 GMT
• inhibrx biosciences reports strong phase 2 response data for inbrx 106 and pembrolizumab combination in head and neck cancer BioPharma APAC Tue, 12 May 2026 23:45:22 GMT
• inhibrx cancer treatment shows high response rates in head and neck cancer study Sahm Tue, 12 May 2026 12:58:46 GMT
• inhibrx says inbrx-106 with pembrolizumab achieves higher response rate in phase 2 trial Moomoo Tue, 12 May 2026 12:10:44 GMT
• Inhibrx announces positive interim results from HexAgon trial Clinical Trials Arena Tue, 12 May 2026 07:00:00 GMT
• Should Positive INBRX-106 Phase 2 Head and Neck Data Require Action From Inhibrx Biosciences (INBX) Investors? Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• analysts have conflicting sentiments on these healthcare companies: apellis pharmaceuticals (apls), fractyl health, inc. (guts) an... The Globe and Mail Tue, 12 May 2026 07:00:00 GMT
• should positive inbrx-106 phase 2 combo data in head and neck cancer require action from inhibrx biosciences (inbx) investors? simplywall.st Tue, 12 May 2026 07:00:00 GMT
• this surging biotech stock shrugs off positive cancer trial results and slips. what to know. -- barrons.com Moomoo Tue, 12 May 2026 05:38:23 GMT
• inhibrx biosciences (inbx) stock soars 17% following impressive phase 2 cancer data MEXC Tue, 12 May 2026 05:36:14 GMT
• inhibrx biosciences (inbx) stock jumps 17% on positive cancer trial results MEXC Tue, 12 May 2026 05:02:04 GMT
• inhibrx biosciences reports positive interim phase 2 results TipRanks Mon, 11 May 2026 21:16:16 GMT
• inbrx106 trial update signals pipeline progress at inhibrx biosciences Traders Union Mon, 11 May 2026 20:17:42 GMT
• inhibrx biosciences (nasdaq:inbx) shares gap up - here's what happened MarketBeat Mon, 11 May 2026 18:37:05 GMT
• inhibrx biosciences, inc. - common stock (nq: inbx The Chronicle-Journal Mon, 11 May 2026 17:56:06 GMT
• inhibrx sees positive ox40 signs | apexonco - clinical trials news and analysis Oncology Pipeline Mon, 11 May 2026 14:54:15 GMT
• amid m&a rumor, inhibrx's ox40-keytruda combo shows promise in early look at midphase data Fierce Biotech Mon, 11 May 2026 14:06:29 GMT
• inhibrx biosciences (inbx) stock jumps 17% on positive cancer trial results CoinCentral Mon, 11 May 2026 13:21:37 GMT
• this surging biotech stock shrugs off positive cancer trial results and slips. what to know. -- barrons.com Moomoo Mon, 11 May 2026 12:26:00 GMT
• a look at inhibrx biosciences (inbx) valuation as investors await phase 2 hexagon webcast results Sahm Mon, 11 May 2026 11:48:04 GMT
• Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data Fierce Biotech Mon, 11 May 2026 07:00:00 GMT
• Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefi... PR Newswire Mon, 11 May 2026 07:00:00 GMT
• Inhibrx Biosciences’ INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• This Biotech Stock Surges After Positive Cancer Trial Results. What to Know. Barron's Mon, 11 May 2026 07:00:00 GMT
• Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Inhibrx reports interim phase 2 data for cancer drug trial Investing.com Mon, 11 May 2026 07:00:00 GMT
• Inhibrx Data Suggests Cancer Drug May Improve Keytruda Effectiveness; Fractyl Begins Diabetes Gene Therapy Trial geneonline.com Mon, 11 May 2026 07:00:00 GMT
• Inhibrx Biosciences (INBX) Stock Soars 17% Following Impressive Phase 2 Cancer Data Blockonomi Mon, 11 May 2026 07:00:00 GMT
• inhibrx biosciences reports positive ph2 trial data, stock gains Investing.com Mon, 11 May 2026 07:00:00 GMT
• inhibrx shares hnscc response data for ox40 agonist reportedly on the takeout table FirstWord Pharma Mon, 11 May 2026 07:00:00 GMT
Inhibrx, Inc(NASDAQ:INBX) 
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Its therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 1 clinical trials in patients with solid tumors, including sarc...
Website: http://www.inhibrx.com
Founded: 2010
Full Time Employees: 75
CEO: Mark P. Lappe
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends